Latest news
Q2 2026 CytomX Therapeutics Inc Earnings Call Transcript - GuruFocusGuruFocus · Sat, 08 Aug 2026 05:27:34 GMTCytomX Therapeutics (NASDAQ:CTMX) Announces Earnings Results - MarketBeatMarketBeat · Sat, 08 Aug 2026 04:52:38 GMTCytomX Therapeutics (CTMX) Stock Faces Revenue Collapse As Pipeline Hopes Carry The Story - simplywall.stsimplywall.st · Sat, 08 Aug 2026 02:30:50 GMTCytomX Therapeutics, Inc. Stock 12‑Month Price Target Cut to $12.38, Implies 267% Upside - TradingViewTradingView · Fri, 07 Aug 2026 21:20:13 GMTState Street Corporation (CTMX) reports 5.4% beneficial stake in CytomX Therapeutics - Stock TitanStock Titan · Fri, 07 Aug 2026 13:21:14 GMTBarclays Maintains CytomX(CTMX.US) With Buy Rating, Maintains Target Price $16 - MoomooMoomoo · Fri, 07 Aug 2026 09:35:00 GMTCytomX Therapeutics Inc (CTMX) (Q2 2026) Earnings Call Highlights: Varetta M Advances Toward ... - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 05:03:00 GMTCytomX Therapeutics secures $37M from Regeneron amid Q2 revenue miss - scanx.tradescanx.trade · Fri, 07 Aug 2026 02:21:26 GMT